Sygnature Discovery

(Image:Getty/ADragan)

Outsourced drug discovery market to top $68bn in 2028

By Maggie Lynch

The global drug discovery market is expected to reach $68bn in 2028, according to a Visiongain report, with revenue gains driven by flexibility, agility, and the ability to innovate, says Evotec executive.

People on the Move: Outsourcing-Pharma roundup March ‘19

People on the Move: Outsourcing-Pharma roundup March ‘19

By Melissa Fassbender

The industry in March saw new c-suite appointments at CRF Bracket, PCI Pharma Services, George Clinical, and Paragon Bioservices – as well as moves to boost medical device and DMPK services at Premier Research and Sygnature Discovery, respectively.

Spotlight

Follow us

Products

View more

Webinars

Featured Suppliers

All suppliers